Skip to content

Comparison of the effects of different administration methods of ketamine on the early postoperative recovery quality of patients with colorectal cancer surgery

Comparison of the effects of different administration methods of ketamine on the early postoperative recovery quality of patients with colorectal cancer surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088917
Enrollment
Unknown
Registered
2024-08-29
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

Group A:Induction with 0.8mg/kg esketamine administered intranasally in combination with endotracheal intubation for general anesthesia.
Group B:Induction with 0.4mg/kg esketamine administered intravenously in combination with endotracheal intubation for general anesthesia.
Group C:Induction with an equivalent volume of saline administered intravenously in combination with endotracheal intubation for general anesthesia.

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective colorectal cancer surgery in our hospital; 2. ASA classification I-III; 3. Normal communication and ability to understand instructions; 4. Expected postoperative stay without ICU admission; 5. Willingness to participate in the study and signing of informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe respiratory or circulatory system diseases such as severe coronary artery disease, chronic obstructive pulmonary disease, etc.; 2. Contraindications to ketamine such as glaucoma, large vessel arterial aneurysm, etc.; 3. Functional impairments that prevent accurate participation in postoperative pain assessment; 4. Severe endocrine system diseases such as pituitary tumors, severe diabetes, etc.; 5. Mental health disorders such as schizophrenia, depression, epilepsy, history of chronic analgesic use, history of alcohol abuse, opioid dependence, etc.; 6. Inability to cooperate with the researchers for any reason, such as hearing or visual impairment, language comprehension difficulties, etc.; 7. History of Parkinson’s disease, stroke, Alzheimer’s disease, insomnia, severe hepatic dysfunction (Child C), renal dysfunction (preoperative dialysis), etc.

Design outcomes

Primary

MeasureTime frame
15 recovery quality scores at 24 hours after surgery ;

Secondary

MeasureTime frame
15 recovery quality scores at 48,72 hours after surgery ;Postoperative 24h, 48h, 72h Richards-Campbell Sleep Questionnaire scores ;Intraoperative and Critical Care Fatigue Score-10 ;VAS grade ;The intraoperative hemodynamics ;The dose of anesthetic drugs used ;Postoperative first bowel gas passage time ;Delirium Incidence Rate ;Frequency of Nausea and Vomiting ;

Countries

China

Contacts

Public ContactGuanghong Xu

The First Affiliated Hospital of Anhui Medical University

xuguanghong2004@163.com+86 138 5694 9535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026